↳ How this is built

Editorial Methodology

How Peptidoteca selects, cites and corrects the research it summarizes.

01 / 04

How we choose sources

Entries lean on peer-reviewed, preferentially open-access literature (PubMed Central, Frontiers, MDPI, Cell Press open access). Preclinical and in-vitro findings are labelled as such.

02 / 04

Citation standard

Claims carry a DOI or PubMed link. Where a publisher page is paywalled we point to the open-access version on PubMed Central when one exists.

03 / 04

Corrections

Email corrections@peptidoteca.com with the page and the specific issue. Corrections or take-downs are issued within ten business days.

04 / 04

Relationship with ReadyPep

Peptidoteca is editorially independent of ReadyPep, the worldwide authorized distributor of Metatide Healthcare research compounds. ReadyPep is the destination we link to; it does not review content before publication.

§ How sources are graded

01Peer-reviewed primary research

The default source — original studies, ranked by model (in-vitro · rodent · human).

02Preprints & conference papers

Used with explicit caveats; flagged as not-yet-peer-reviewed.

03Reputable secondary references

Textbooks, regulatory docs, curated chemistry databases (PubChem, DrugBank).

✕ Marketing · forums · unsourced claims — never used as evidence

For in-vitro research at registered institutions only. Not for human or veterinary consumption. Not approved for therapeutic use by any regulatory body.